Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-25 @ 4:57 AM
NCT ID:
NCT01175018
Eligibility Criteria:
Inclusion Criteria:
* Patients with STEMI will be asked to enroll according to the following inclusion criteria:
* age \> 18 years,
* acute (\<12 h) onset of chest pain associated with ST segment elevation (\>2 mm) in 2 or more anatomically contiguous leads at ECG,
* and successful primary percutaneous coronary intervention.
Exclusion criteria:
* inability to give informed consent,
* late presentation (\>12 h),
* unsuccessful revascularization procedure,
* hemodynamic instability including hypotension,
* prior Q-wave AMI,
* end-stage congestive heart failure (American Heart Association \[AHA\]/American College of Cardiology \[ACC\] class C-D, New York Heart Association IV), severe left ventricular dysfunction (EF\<20%),
* severe valvular heart disease,
* pregnancy, dye allergy or contraindications to cardiac angiography and/or magnetic resonance imaging, coagulopathy (INR\>1.5 or platelet count\<50000/mm3),
* recent (\<14 days) use of anti-inflammatory drugs (not including NSAIDs),
* chronic inflammatory disease (including but not limited to rheumatoid arthritis, systemic lupus erythematosus), and malignancy or any comorbidity limiting survival or conditions predicting inability to complete the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
110 Years
Study:
NCT01175018
Study Brief:
Protocol Section:
NCT01175018